Jeena Sikho Lifecare Receives BSE In-Principle Approval for ESOS 2024 Shares
Jeena Sikho Lifecare Ltd · Others (Uncategorized) · 23 Sept 2026, 5:52 pm
Jeena Sikho Lifecare Receives BSE In-Principle Approval for ESOS 2024 Shares Jeena Sikho Lifecare Limited received in-principle approval from BSE on 22nd Sep'26 for listing up to 6,50,000 equity shares (face value ₹2 each) under its Employee Stock Option Scheme 2024 (ESOS 2024). The company previously secured approval from NSE on 14th Mar'24. Following a stock split from a face value of ₹10 to ₹2 per share, the original 1,30,000 approved shares were adjusted to 6,50,000 equity shares. The company now holds required listing approvals from both NSE and BSE for ESOS 2024 share issuances.
Original exchange filing (PDF)
More announcements from Jeena Sikho Lifecare Ltd
- Commencement of operations at the new Client Support Centre Facility at Noida, Uttar Pradesh. · 18 Nov 2026
- Submission of audio recording of Earnings Conference Call - Q2 FY 2026-27 · 16 Nov 2026
- Submission of Investor Presentation · 16 Nov 2026
- Jeena Sikho Lifecare Limited has submitted to the Exchange, Outcome of the Meeting of the Board of Directors of Jeena Sikho Lifecare Limited held on November 14, 2026 for the declaration of Unaudited financial results (Standalone and Consolidated) for the period ended September 30, 2026. · 15 Nov 2026
- Declaration of Unaudited Financial Results (Standalone & Consolidated) for Quarter and Half year ended 30.09.2026 · 15 Nov 2026
- Unaudited Financial Results (Standalone & Consolidated) for quarter and half year ended 30.09.2026 · 15 Nov 2026
- Intimation of Schedule of Analyst / Investor Meet/ Conference under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 · 13 Nov 2026
- Incorporation of Subsidiary Company · 11 Nov 2026
